Glucagon-like peptide-1 (GLP-1) drugs help people lose weight by making them feel fuller with less food and by signaling the brain that the stomach contains food, reducing their appetite and cravings
Liver is also one of the foods rich in selenium which gives it a leg up when it comes to reducing free radical formation
GLP-1 receptor agonists improve endothelial function Phase 3 status / Phase 3 trials ongoing as of mid-2025
GLP-1 drugs, such as semaglutide, are often prescribed for managing obesity and type 2 diabetes, and are known to lower blood sugar, reduce body weight, and decrease cardiovascular risk
Katsimichas T, Theofilis P, Tsioufis K, et al
This dual mechanism makes it particularly effective for patients whose weight gain is driven by emotional eating, food cravings, or the "reward" component of overeating